Ulcerative Colitis Diet Plan: What to Eat & Avoid

Ulcerative colitis is a chronic condition causing inflammation in the colon and rectum. It affects millions of people worldwide, leading to symptoms such as abdominal pain, diarrhea, loss of appetite, and rectal bleeding that can make day-to-day life challenging.

IV Fluids Fully in Stock

Reliable supply for uninterrupted care
Get Started

While diet doesn’t cause this disease, it can help manage the symptoms. To follow an ulcerative colitis diet plan, you must eat certain foods and avoid others.

This guide will introduce you to some of the best anti-inflammatory foods for ulcerative colitis. We will also show you what you can and can’t eat while experiencing flare-ups and managing your disease with total parenteral nutrition (TPN).

The Role of Diet in Ulcerative Colitis

Ulcerative colitis flare-ups can be debilitating and put unnecessary stress on the colon. Although you can eat while on TPN and deal with these flare-ups, the type of diet you follow is important.

An optimized ulcerative colitis diet plan can reduce the stress on your colon and help you overcome flare-ups more quickly.

A good diet consists of low-residue foods. These foods will leave less undigested grit in the stool and cause less irritation while exiting the rectum. Binding foods are also ideal for those with ulcerative colitis.

Meanwhile, foods that cause inflammation or disrupt the balance of helpful bacteria in the gut can worsen the symptoms. Below are some foods you should eat and foods you must avoid to manage your symptoms as best as possible.

Foods To Include in Your Ulcerative Colitis Diet Plan

Here are some of the best anti-inflammatory foods for ulcerative colitis that can make living with TPN and managing symptoms easier.

Omega-3 Fatty Acids

Studies show that foods rich in omega-3 fatty acids can alleviate ulcerative colitis symptoms such as intestinal inflammation.

Some of the foods you can eat for more of these healthy fats include:

  • Fish oil supplements
  • Fatty fish (mackerel, salmon, etc.)
  • Plant oils (flaxseed oil, walnut oil, etc.)

Probiotics

Probiotics are another group of foods you should include in your ulcerative colitis diet plan. Probiotics are live bacteria and yeast that encourage remissions and help the body experience fewer flare-ups.

You can get more probiotics by eating:

  • Kefir
  • Yogurt
  • Kimchi
  • Sourdough bread

Protein

Protein-rich options are some of the best anti-inflammatory foods for ulcerative colitis. Foods high in protein can help repair tissues that have been damaged from inflammation and prevent ulcerative colitis flare-ups.

Opt for lean protein options like the ones below to manage your symptoms:

  • Tofu
  • Eggs
  • Turkey
  • Chicken breast
  • Lean cuts of beef

Legumes are another food group high in protein. However, they can trigger flare-ups in some people, so, it’s best to limit them. Instead, add proteins from the list above to your ulcerative colitis diet plan.

Cooked Fruits and Vegetables

People with ulcerative colitis should avoid fibrous foods such as fruits and vegetables. However, they can opt for the cooked versions of these food groups that allow for easier absorption of nutrients.

Some of the safest cooked fruits and vegetables you can include in your diet are:

  • Pears
  • Apples
  • Carrots
  • Pumpkin
  • Potatoes
  • Bananas

Get Financial Assistance

(877) 778-0318

Foods To Exclude from Your Ulcerative Colitis Diet Plan

Fruits and vegetables

Those with ulcerative colitis must eliminate the following foods from their diets.

Insoluble Fiber Foods

Insoluble fiber foods are foods containing fiber that doesn’t dissolve in water. These foods can worsen ulcerative colitis symptoms, so it’s best to avoid them.

Some foods high in insoluble fiber include:

  • Raw fruits and vegetables
  • Nuts (almonds, walnuts, etc.)
  • Seeds (sunflower seeds, chia seeds, etc.)
  • Whole grains (oats, barley, quinoa, brown rice, etc.)

Processed Meats

If you’re looking for the best anti-inflammatory foods for ulcerative colitis, you can’t find them in processed meats. You should exclude processed products like sausages, ham, bacon, and salami from your ulcerative colitis diet plan.

Studies show that reducing red meat consumption and eating white meat alternatives can also benefit ulcerative colitis patients.

Lactose Products

Lactose is another substance you should avoid if you have ulcerative colitis. This sugar is found in dairy products like milk and cheese and can trigger symptom flare-ups in some individuals.

Alcohol and Sugar Alcohols

Alcoholic drinks like beer and wine can worsen ulcerative colitis symptoms. It’s best to avoid them and opt for healthier beverages instead.

You should also limit sugar alcohols such as sorbitol and xylitol. These substances are found in sugar-free products like candies and chewing gums and cannot be digested by your digestive tract.

Carbonated Drinks

You should also remove carbonated drinks from your ulcerative colitis diet plan. Carbonated drinks like sodas can irritate your digestive system and cause gas.

Some studies even show a link between drinking these beverages and developing ulcerative colitis.

Sugary Foods

Sweets and sugary foods can also cause flare-ups. Some sweets you may want to avoid if you’re dealing with ulcerative colitis include:

  • Cakes
  • Juices
  • Honey
  • Pastries
  • Ice creams

High-Fat Foods

Foods high in saturated fats can be a source of flare-ups. It’s best to remove high-fat foods in the list below from your ulcerative colitis diet plan:

  • Butter
  • Margarine
  • Fried foods
  • Fast food items
  • Coconut oil and palm oil

Get Copay Assistance Now

(877) 778-0318

Spicy Foods

Spicy foods are not among the best anti-inflammatory foods for ulcerative colitis. They can cause irritation and worsen your symptoms.

Some of the spicy foods you may want to avoid include:

  • Chillies
  • Hot sauces
  • Hot peppers
  • Spicy seasonings
  • Spicy pickles and relishes

Gluten

Studies show that gluten, a protein in foods such as wheat and barley, can worsen inflammatory bowel disease (IBD) symptoms.

While ulcerative colitis is not the same as IBD, patients can still suffer from gluten consumption, especially since they can also have a gluten intolerance.

The Best Ulcerative Colitis Diet Plans

A plate with fish and cooked vegetables

While following the above guidelines is a great place to start, there is no one-size-fits-all diet for this autoimmune condition. What works for others may not work for you, and vice versa.

However, research shows that certain anti-inflammatory diet plans may be more beneficial than others for individuals with ulcerative colitis. Let’s look at some of these diets.

Mediterranean Diet

There is notable research suggesting that the Mediterranean diet can benefit those with ulcerative colitis. This anti-inflammatory diet is rich in nutritious plant foods, seafood, and olive oil while limiting red meat and alcohol consumption.

A 2021 study showed that the Mediterranean diet lowers disease activity in those with inflammatory disorders. Another study suggested that this diet plan for ulcerative colitis can reduce inflammatory markers and alleviate symptoms in children with IBD.

Low FODMAP Diet

The low FODMAP diet is another diet rich in some of the best anti-inflammatory foods for ulcerative colitis.

FODMAP stands for fermentable oligosaccharides, disaccharides, monosaccharides, and polyols. These are all substances that may cause symptoms flare-ups in people with ulcerative colitis.

A diet low in these compounds may alleviate the symptoms and keep the disease from worsening.

Paleo Diet

Paleo is another effective diet plan for those with ulcerative colitis. The paleo diet’s concept is to consume foods similar to what our hunter-gatherer ancestors used to eat.

That means limiting refined foods, whole grains, and dairy products while eating more fish and lean meats, which are among the best anti-inflammatory foods for ulcerative colitis.

Studies evaluating the effects of the autoimmune protocol (AIP) diet (an extension of the paleo diet) on IBD patients showed significant remission rates in a short period.

While more research is necessary to confirm the beneficial effects of the paleo diet for ulcerative colitis, the current findings are promising. You can speak with your doctor and give the paleo diet a try if they deem fit.

How To Know Which Foods in Your Ulcerative Colitis Diet Plan Are Triggering Flare-ups?

Just like you should track TPN’s metabolic complications and side effects, you should also monitor which foods worsen your symptoms.

Keeping a food journal is the best way to identify foods that are causing flare-ups. Write down everything you eat and drink throughout the day and any immediate reactions or symptoms you experience.

Recording your foods can help determine the safest dietary options for your condition. You can also share your food diary with your physician to give them further insight and allow them to make more informed decisions for your health needs.

Receive At-Home TPN Therapy for Ulcerative Colitis from AmeriPharma® Specialty Pharmacy

Now that you know which foods to eat and which to avoid, you can create an optimized ulcerative colitis diet plan for yourself. Try the best anti-inflammatory foods for ulcerative colitis and use our guide to manage symptoms.

If you’re looking for at-home TPN treatments for ulcerative colitis, AmeriPharma® Specialty Pharmacy can help.

We discreetly package TPN home infusion materials and deliver them to your door. Our specialty pharmacy can also send specialized infusion nurses to your home to administer the treatment and help you troubleshoot any problems.

Contact us now to receive specialty care at home and meet your dietary needs with our full-service coordination, 24/7/365 support, and copay assistance.

How To Wean off TPN in Adults

Total parenteral nutrition (TPN) is a life-saving solution for many adults. However, long-term TPN use can have negative effects on the body. The good news is that weaning off TPN is possible.

Always in Stock

Full inventory of IV fluids, ready for you
(877) 778-0318

It might seem daunting at first. However, with careful planning and expert guidance from a healthcare provider, adults can safely transition off TPN and onto oral nutrition.

Below, we will explore the steps and considerations involved in how to wean off TPN in adults. From setting goals to implementing a plan and addressing challenges, we will provide the information necessary for a successful transition.

Step 1: Assess Readiness

When living with TPN, infusions become a part of your daily routine. This can make weaning off TPN challenging for many. So, before anything, a healthcare provider must assess the TPN recipient’s readiness for transition to a regular oral diet.

Here are some of the factors healthcare providers will consider:

1.1. Monitor Nutritional Status

The first step in assessing a patient’s readiness for returning to an oral diet is monitoring their nutritional status.

This step involves evaluating the individual’s:

  • Weight
  • Vitamins and mineral levels
  • Body mass index (BMI)

The patient may be ready to wean off TPN if they demonstrate:

  • Stable weight
  • Improved nutrition markers
  • Adequate wound healing 
  • Presence of bowel sounds
  • The ability to meet their nutritional needs through enteral feeding

1.2. Evaluate the Gastrointestinal Function

Evaluating the gastrointestinal function is essential when considering how to wean adults from TPN. Doctors must ensure a patient’s gastrointestinal tract can absorb nutrients and fluids before switching to feeding using the gut.

This step involves:

  • Assessing the individual’s ability to digest and absorb nutrients
  • Assessing for signs of gastrointestinal intolerance, such as:
    • Bloating
    • Vomiting
    • Diarrhea
    • Constipation
    • Malabsorption
    • Abdominal pain

Any signs of gastrointestinal complications may indicate a need for further evaluations or adjustments to the enteral feeding plan before weaning someone from TPN.

1.3. Consider Overall Health

Besides nutritional status and gastrointestinal function, doctors must also consider a patient’s overall health status. Some of the factors that can impact the successful transition to enteral feeding include the individual’s:

  • Surgical history
  • Current medications
  • Underlying medical conditions

Healthcare providers must assess these factors by closely monitoring a patient’s:

  • Vital signs
  • Clinical symptoms
  • Fluid intake and output

If the individual is in good overall health, they may be ready to stop relying on TPN for their nutritional needs.

AmeriPharma Specialty Care

Leader In TPN Assistance
Schedule a Consultation

Step 2: Set Goals for Weaning From TPN

A doctor talking to a patient

The next step in how to wean adults from TPN is setting realistic goals and creating a plan. Here are the further steps involved in this stage.

2.1. Establish Realistic Goals for Nutrition and Hydration

First and foremost, a healthcare provider must determine the appropriate caloric and fluid intake needed for the patient to maintain their health.

Healthcare providers can consult dietitians and other professionals to determine the nutritional requirements of each individual. These requirements will differ based on each person’s:

  • Age
  • Height
  • Weight
  • Activity level
  • Underlying medical conditions

By assessing these factors, healthcare providers can set specific, realistic goals for each individual’s caloric and fluid intake to ensure they receive adequate nutrition and hydration.

2.2. Create a Timeline for Weaning Off TPN

Besides setting specific goals, healthcare providers must create a realistic timeline and decide how they want to wean adults from TPN. Weaning off TPN is a gradual process. Stopping TPN abruptly can lead to nutrition consequences and metabolic complications such as electrolyte or micronutrient deficiencies as well as rebound hypoglycemia (low blood sugar).

This timeline should be tailored to each individual’s needs and may vary depending on their:

  • Nutritional intake
  • Current health status
  • Ability to tolerate oral nutrition

Successful transition from TPN to oral feeding relies on a feasible plan adjusted regularly to meet the patient’s unique needs. Some may need this transition to be gradual to avoid any potential complications.

2.3. Involve the Individual in the Decision-Making Process

Involving adult patients in the decision-making when setting goals for weaning off TPN is also crucial. Patients should actively participate in their healthcare decisions and have a say in their treatment plans.

An individual’s active participation in the process may include:

  • Discussing their preferences for oral nutrition
  • Addressing any concerns or limitations they may have
  • Providing education and support throughout the weaning process

This approach empowers individuals and increases the overall success of the weaning process.

Step 3: Implement a Transition Plan

Weaning adults from home TPN therapy requires a careful and systematic transition strategy. Here are some of the factors to consider for a successful transition plan.

3.1. Introduce Enteral Nutrition Options

When implementing a transition plan, it’s vital to understand how to wean adults from TPN properly with the best enteral nutrition options. The most common options to start with include:

  • Tube feeding
  • Blended foods
  • Oral supplements

When choosing the best option for a patient, healthcare providers must consider their:

  • Preferences
  • Medical history
  • Nutritional needs

It’s crucial to involve a dietician in the decision-making process and start with slow volumes to allow the gut to adapt to the new diet.

Ask About TPN Home Infusion

(877) 778-0318

3.2. Monitor for Signs of Malnutrition or Dehydration

Another step in implementing a transition plan and successfully weaning adults from TPN is monitoring for signs of malnutrition and dehydration.

Malnutrition occurs if the patient doesn’t receive enough calories and essential nutrients. Symptoms of malnutrition include:

  • Fatigue
  • Muscle loss
  • Unintended weight loss
  • Reduced appetite
  • Impaired wound healing

Dehydration occurs if the patient doesn’t consume enough fluids. Symptoms of dehydration include:

  • Dry mouth
  • Dark urine
  • Decreased urine output
  • Dizziness
  • Dry lips or tongue

Regularly monitoring the patient’s weight, lab results, fluid levels, and clinical symptoms is crucial to detect any imbalances and ensure a smooth transition from TPN.

3.3. Adjust the Plan Based on the Patient’s Response

Lastly, weaning adults from TPN requires adjusting the transition plan based on each individual’s responses. Some patients may experience the following gastrointestinal issues when starting an alternative diet:

  • Bloating
  • Nausea
  • Diarrhea
  • Constipation

In these cases, healthcare providers must adjust how they wean adults from TPN to ensure a successful transition. For instance, they might need to:

  • Adjust the TPN feeding rate
  • Change the type of nutrition formula used
  • Modify the diet to meet the person’s needs better

Regular follow-up appointments with a healthcare provider are essential. During these appointments, they can assess the patient’s progress and modify the transition plan if needed.

Step 4: Evaluate Progress

After implementing a plan to wean adults from TPN, healthcare providers must evaluate their progress to ensure a smooth transition. Here are the steps involved in this stage of the process:

4.1. Regularly Assess the Patient’s Nutritional Intake and Absorption

Regularly assessing the patient’s nutritional intake and absorption is how healthcare providers can wean adults from TPN to ensure a smooth transition. This assessment can include an evaluation of the patient’s:

  • Fluid intake
  • Caloric intake
  • Protein intake

Healthcare providers can keep track of a patient’s dietary intake by:

  • Examining their food journal
  • Monitoring their weight fluctuations
  • Assessing any signs of nutrient deficiency or malabsorption issues

4.2. Monitor for Complications and Side Effects

While TPN has several risks, weaning off it may also cause complications and side effects. These side effects are even more prominent in those who have been on TPN for an extended period.

Some of the complications patients might experience include:

  • Dehydration
  • Low blood sugar
  • Electrolyte imbalances

Physicians can control any complications or side effects by regularly checking the essential nutrient levels in an individual’s blood sample and evaluating their vital signs.

Get Financial Assistance for TPN

Get Started

Step 5: Address Challenges and Barriers

A man holding his bloated belly

The final step involved in how to wean adults from TPN is addressing the physical and mental challenges.

5.1. Deal With Resistance From the Patient

Weaning off TPN may be a scary concept to many patients since they have become dependent on it. They may be anxious about transitioning to oral nutrition.

Therefore, healthcare providers must have a plan for dealing with this resistance. They must:

  • Offer emotional support
  • Take the time and listen to the patient’s concerns
  • Educate individuals about the weaning process and its potential benefits

Making patients feel heard can reduce some of their worries and make the transition easier.

5.2. Manage Gastrointestinal Issues

Another challenge when weaning off TPN in adults is managing gastrointestinal issues. People transitioning from TPN to a regular diet may experience the following:

  • Nausea
  • Bloating
  • Diarrhea
  • Vomiting
  • Constipation

Doctors can recommend medications and supplements to alleviate these symptoms and make the transition less challenging.

5.3. Provide Resources for Managing Enteral Nutrition at Home

Finally, doctors must provide patients with the necessary resources and support to ensure a smooth transition.

Just as they should guide patients through troubleshooting TPN and recognizing side effects when starting treatment, they must help them navigate the transition journey.

Healthcare providers can help patients by creating individualized meal plans for them and addressing their issues.

Receive At-Home TPN Therapy With AmeriPharma® Specialty Pharmacy

Now that you know how to wean from TPN, you’re ready to make the transition. If you’re not weaning off TPN but only starting your treatments, AmeriPharma® Specialty Pharmacy can help.

We deliver TPN home infusion materials to your door in discreet packaging and help you troubleshoot any problems.

Our specialty pharmacy can also send specialized infusion nurses to your home to administer the treatment. You can meet your dietary needs with our full-service coordination, 24/7/365 support, and copay assistance.

Contact us now to speak to a patient navigator and receive specialty care at home.

Mekinist: A Comprehensive Guide

Mekinist (trametinib) is a cancer drug developed by Novartis Pharmaceutical Corporation. The FDA first approved this drug on May 29, 2013 [1]. It is a targeted therapy that can treat some specific types of cancer, and it can limit the growth and spread of cancer cells. Mekinist has shown remarkable clinical trial results and is being praised for its potential in cancer treatment. In this article, we will discuss everything you need to know about Mekinist, including how it works, its dosage and treatment, and its potential benefits and risks.

Speak to a Specialist

About Copay Assistance
(877) 778-0318

What Is Mekinist?

Mekinist (trametinib) is a targeted cancer therapy medicine that is used to treat certain types of cancers. It belongs to a class of medicine called kinase inhibitors. It blocks the action of an abnormal protein that signals the cancer cells to multiply. Therefore, the growth of cancer cells stops or slows down. 

The FDA approved Mekinist for the treatment of certain types of cancers, including melanoma, lung and thyroid cancer, and certain types of tumors. Mekinist is often used in combination with other medicines.

What Is Mekinist Used to Treat?

Mekinist is a brand-name medication. It is FDA-approved to treat certain types of cancers. They include [3]:

Melanoma: Mekinist is used to treat melanoma (skin cancer) that is caused by a specific gene mutation (BRAF V600E or V600K mutation) and which cannot be surgically removed or has spread to other parts of the body. It is often used in combination with another medicine called dabrafenib.

Non-Small Cell Lung Cancer (NSCLC): This is a type of lung cancer that causes symptoms like a persistent cough, chest pain, and fatigue. Mekinist, in combination with dabrafenib, is used to treat NSCLC patients with a specific mutation (BRAF V600E) whose cancer has spread to other parts of the body. 

Anaplastic Thyroid Cancer (ATC): ATC is a type of thyroid cancer that can cause symptoms like difficulty breathing. Mekinist, in combination with dabrafenib, is used to treat ATC patients with a specific mutation (BRAF V600E) whose cancer is advanced or has spread, and there are no other good treatment options.

Solid Tumors: Mekinist, in combination with dabrafenib, can be used to treat solid tumors in adults and children (1 year or older) with BRAF V600E mutation whose cancer has worsened after previous treatment and there are no other satisfactory options.

Low-Grade Glioma (LGG): This is a type of brain tumor that can cause symptoms like headache, vision problems, and severe vomiting in children. Mekinist, in combination with dabrafenib, can be used to treat LGG with BRAF V600E mutation in children 1 year or older.

How Does Mekinist Work?

Mutations in the BRAF gene (particularly BRAF V600E or V600K) cause uncontrollable cell growth in some cancers, including melanoma and non-small cell lung cancer. Mekinist works by blocking the activity of the mutant BRAF gene. This action slows or stops the growth of cancer cells. Mekinist, when used alone or in combination with other medications such as dabrafenib, can successfully reduce tumor size and control cancer progression [3].

Side Effects of Mekinist

Mekinist is an FDA-approved medicine for the treatment of certain cancers. Like any medication, it can have side effects. Some of the side effects can be severe. Side effects of Mekinist are as follows [2]:

Mild Side Effects

Woman suffering from headache as a result of taking Mekinist

Mild side effects include the following:

  • Fever
  • Rash
  • Diarrhea
  • Fatigue
  • Headache
  • Vomiting
  • Joint and muscle aches
  • Swelling of the face, arms, and legs

These mild side effects may only last a few days to a few weeks. However, if these side effects do not go away or become worse, consult your doctor.

Get Financial Assistance

Schedule a Consultation

Serious Side Effects

The serious side effects include the following:

Risk of New Cancers: When this medication is used in combination with dabrafenib, there is a risk of developing some types of skin cancers. So, it is important to check your skin regularly. If you find changes in your skin, such as new warts, sores, or moles that change in size or color, immediately report them to your doctor.

Heart Problems: Mekinist can cause severe heart problems such as cardiomyopathies or a severe increase in blood pressure. Symptoms of cardiomyopathies include an irregular or fast heartbeat, shortness of breath, and fatigue.

Eye Problems: This medication can cause severe eye problems. It can even lead to blindness. Symptoms of eye problems include blurred vision, seeing colorful dots, and eye pain.

Intestinal Inflammation or Tears: Mekinist can cause inflammation or tears in your stomach. This can be life-threatening. Symptoms include diarrhea, stomach pain, fever, and nausea.

Bleeding Problems: This medication can cause severe bleeding, especially in the brain or stomach. It can be fatal. Inform your doctor and seek medical attention if you experience red or black tarry stools, stools that are bright red or look like coffee grounds, headache, weakness, or coughing up blood.

Blood Clots: Mekinist can cause blood clots in the arms and legs. These clots can travel to the lungs and be fatal. Symptoms include chest pain, sudden shortness of breath, and leg pain or swelling.

Please note that the list of side effects provided here doesn’t contain all the possible side effects. Consult your doctor immediately if you encounter any severe side effects.

Dosing

Mekinist is available as an oral tablet that comes in two strengths: 0.5 mg and 2 mg. It is also available as an oral powder. Your pharmacist can mix the powder with water that you can swallow. 

The recommended dose for adult patients is 2 mg, taken orally once daily. 

The recommended dose for children is based on their body weight. 

Take Mekinist at least 1 hour before or 2 hours after a meal. Try to take the medicine at the same time each day. If you vomit after taking the medication, do not take an additional dose. Just take the next dose at the scheduled time.

Cost

Mekinist costs about $16,700 for a supply of 30 2 mg oral tablets [4]. However, the actual cost depends on your location, insurance coverage, treatment plan, and the pharmacy you visit. 

FAQs

Here are some frequently asked questions about Mekinist:

Is Mekinist a type of chemotherapy?

No. Mekinist belongs to a class of medication known as kinase inhibitors [3]. It doesn’t work like typical chemotherapy medications. Instead, it works by blocking specific proteins that promote the growth of cancer cells.

Does it cure cancer?

No. Mekinist cannot cure cancer. But it can help you manage the disease by slowing the progression of your cancer. 

Does Mekinist cause hair loss?

No. The prescribing information of Mekinist doesn’t include hair loss as a side effect. However, when it was administered in children in combination with dabrafenib for the treatment of low-grade glioma, hair loss was seen as a side effect [3]. In other cases, hair loss is not mentioned as a side effect. 

Can I use Mekinist during pregnancy or breastfeeding?

According to studies, Mekinist can cause fetal harm to the unborn baby when given to a pregnant lady [3]. Thus, it is advised that men and women with reproductive potential should use effective contraceptive methods during treatment and for 4 months after the last dose. 

No available data suggests the presence of Mekinist in human milk. However, considering the potential danger that it poses to the newborn, it is advised that women should not breastfeed during treatment and for 4 months after the last dose.

Hemophilia and Women’s Health: How Hemophilia Affects Menstruation, Pregnancy, and Childbirth

Hemophilia is a rare genetic disorder that makes it hard for blood to clot. It can lead to long bleeding episodes, even from minor cuts. While hemophilia mostly affects men, women can also be affected, especially as carriers or, in rare cases, as patients. Women who have hemophilia face special challenges during their menstruation, pregnancy, and childbirth. In order to manage these conditions properly, we need to understand hemophilia and the risks it can cause. In this article, we will talk about hemophilia and women’s health and how hemophilia affects women during menstruation, pregnancy, and childbirth.

Speak to a Specialist

About Copay Assistance
(877) 778-0318

Hemophilia and Women’s Health

Hemophilia is a rare genetic disease that affects the blood’s ability to form clots. The majority of hemophilia patients are men born with this disease since it is passed down from parents to children. Women can also have hemophilia, though it is much rarer. A recent study collected data on women with hemophilia in the USA [1]. It found that between 2012 and 2020, only 1,667 women received treatment for hemophilia in hemophilia treatment centers (HTC). Of them, only 51 women had severe hemophilia, and 79 of them had moderate hemophilia. Mild hemophilia was the most common in women, occurring in 1,537 women. According to available data, it is estimated that the number of women with hemophilia worldwide is about 360,000, both diagnosed and undiagnosed [3].

Hemophilia is caused by a mutation in one of the X chromosome genes, passed down from parents to children. Men have only one X chromosome, so they will have hemophilia if they inherit a mutated gene. But women have two X chromosomes. So, if they inherit one mutated gene in one X chromosome, the other normal gene in the other X chromosome will offer some protection. These women usually have no symptoms and live normal lives, and they are known as carriers. However, about 30% of female carriers experience abnormal bleeding, such as heavy and prolonged menstrual periods [4]. In rare cases, some women receive two defective genes — one from each parent — or receive one defective gene, but their other X chromosome is not working. These women experience severe bleeding symptoms just like men [2].

How Hemophilia Affects Menstruation

Hemophilia can cause great challenges for women, especially concerning menstruation. Some of the complications that hemophilia creates regarding menstruation are [5]:

Heavy Menstrual Bleeding: Women with hemophilia or carriers of the gene often experience heavy menstrual bleeding. This leads to significant blood loss, and they need to change sanitary products frequently. It also leads to complications like anemia, fatigue, weakness, etc.

Prolonged Periods: Hemophilia can increase the duration of your menstrual period. Your period can last longer than the typical duration of 3 – 7 days.

Intermenstrual Bleeding: You may experience bleeding between your regular menstrual periods. This irregular bleeding can make it hard for you to manage your menstrual health.

To manage these complications, you may consult with hemophilia treatment center (HTC) providers.  They can prescribe hormonal therapies like birth control pills, which can reduce the severity of bleeding. They might also prescribe iron supplements to combat anemia caused by heavy menstrual bleeding.

How Hemophilia Affects Pregnancy

Hemophilia and Women’s Health: Pregnant woman with hemophilia

Women with hemophilia are at an increased risk of bleeding, especially during delivery and postpartum. During pregnancy, their blood clotting factors fluctuate. These clotting factors are essential for forming blood clots. So, it is important to regularly check the levels of the clotting factors and use clotting factor concentrates if necessary. 

Women who have hemophilia or who are carriers have a chance of passing the mutated gene to their children. If a son inherits the mutated gene, he will have hemophilia. If a daughter inherits the mutated gene, she will be a carrier; in rare cases, she might have hemophilia. Therefore, it is important to  receive genetic counseling and testing, which can determine the chances of having a child with hemophilia.

Women with hemophilia can have other complications such as miscarriage, preterm labor, etc. It is necessary to plan your pregnancy with your doctor to ensure a safe pregnancy [2][6].

Get Financial Assistance

Schedule a Consultation

How Hemophilia Affects Childbirth

Hemophilia can create many complications regarding childbirth. One of them is the increased risk of bleeding during childbirth. Women with hemophilia can have vaginal delivery or cesarean section, depending on their individual situation. Both of these procedures can cause significant blood loss due to the body’s impaired ability to form blood clots. To manage the bleeding risk, your doctor may administer clotting factor concentrates before, during, and after delivery.

Another major concern for women with hemophilia is postpartum hemorrhage (excessive bleeding after childbirth). It can occur within 24 hours after delivery or several days later. Close monitoring is necessary to ensure safety.

After the delivery, it is important to test the newborn for hemophilia. However, proper diagnosis is not always possible at birth. Hence, the baby is tested for hemophilia again when they are 6 months old to confirm the diagnosis [2].

Remember, managing childbirth with hemophilia requires careful planning, medical treatment, and proper support. With the right management strategies, you can have a safe delivery and ensure the best possible outcomes for you and your baby.

Von Willebrand Disease vs. Hemophilia: Comparing the Causes, Symptoms, Diagnosis, and Treatments

Von Willebrand disease (VWD) and hemophilia are inherited blood disorders. Both disorders make it harder for your blood to clot. While some symptoms may overlap, these conditions aren’t the same. Differences also exist in the way they are diagnosed and treated. 

Get Financial Assistance

(877) 778-0318

Von Willebrand Disease vs. Hemophilia: A Quick Overview

Von Willebrand disease (VWD) is the most common inherited bleeding disorder in which the blood doesn’t clot normally. Over 3 million people in the United States live with VWD [1].

VWD happens when the blood is deficient in a clotting protein (clotting factor) called von Willebrand factor. It can also result due to a defective von Willebrand factor. 

Hemophilia is also an inherited bleeding disorder in which the affected individual lacks clotting factor VIII or IX, or rarely XI. It is less common than VWD, affecting about 30,000 Americans [2].

Hemophilia primarily affects males, while VWD is as common in males as it is in females.

VWD symptoms tend to be milder than those with hemophilia.

Von Willebrand Disease vs. Hemophilia: Comparing the Symptoms

VWD and hemophilia share several symptoms, including:

  • Easy bruising 
  • Recurring or severe nosebleeds
  • Unusual bleeding after a trauma or injury
  • Heavy bleeding after minor surgery, dental work, or vaccination
  • Heavy or abnormally long menstrual bleeding

Internal bleeding may occur in severe cases, leading to:

  • Painful or stiff joints and muscles 
  • Accumulation of blood under the skin (hematoma)
  • Blood in the urine or stool
  • Low number of red blood cells (anemia)

People with VWD often report bleeding in the nose, mouth, intestines, uterus, and vagina. On the other hand, hemophilia is more likely to cause bleeding in the joints and within muscles.

What Test Is Used To Differentiate von Willebrand Disease from Hemophilia?

Blood Tests for VWD 

  • Von Willebrand factor antigen

This test measures blood levels of von Willebrand factor.

  • Von Willebrand factor activity

This test helps determine if the von Willebrand factor works properly during the clotting process. 

  • Factor VIII clotting activity

This measures the level and activity of factor VIII.

  • Von Willebrand factor multimer

This helps your healthcare provider determine the type of von Willebrand disease. 

Diagnostic Tests for Hemophilia

  • Screening tests

These include blood tests that measure how long your blood takes to form a clot. 

  • Factor assays

Also called clotting factor tests, they measure how well clotting factors VIII and IX work during the clotting process. 

Speak to a Specialist

About Copay Assistance
Schedule a Consultation

Von Willebrand Disease vs. Hemophilia: Comparing Treatments

Von Willebrand Disease Treatment

Doctor's hand holding a test tube with a blood sample

Minor bleeds in von Willebrand disease might not require treatment. In such cases, your healthcare provider will ask you to avoid certain medications, such as blood thinners (like aspirin).

Treatment for VWD can vary depending on the type and severity of the symptoms. For milder cases, a medicine called desmopressin acetate is administered, either by injection or a nasal spray. 

In more severe cases, you may need injections of lab-created von Willebrand factors. A healthcare provider may consider such injections in milder cases that don’t improve with the desmopressin acetate nasal spray. 

Hemophilia Treatment

Hemophilia treatment involves injections of lab-created clotting factors to replace missing factor VIII or IX, depending on the type of hemophilia. Treatment products may include:

  • Emicizumab (Hemlibra)
  • Desmopressin acetate
  • Amicar
  • Gene therapy, such as Roctavian and Hemgenix

Von Willebrand Disease vs. Hemophilia: Frequently Asked Questions

Is factor VIII the same as von Willebrand?

No. Though they work closely as a complex (FVIII/VWF), they are different proteins. 

Why is it called von Willebrand disease?

The disease is named after Finnish physician Erik Adolf von Willebrand. In 1926, he published a paper describing bleeding disorders in three generations. He also distinguished the condition from hemophilia and other bleeding disorders known at the time. 

What are other names for the von Willebrand factor?

Other names for the von Willebrand factor are factor VIII-related antigen and ristocetin cofactor. However, health experts rarely use these names nowadays.

The Essential Guide to Medicare IVIG Coverage

Medicare provides coverage for IVIG and SCIG therapies in many instances, but navigating the details can sometimes be difficult. This guide will provide an overview of how IG therapies are covered under Medicare.

Medicare will provide coverage for IVIG based on:

  • The diagnosis
  • The location of therapy
  • The route of administration 

Diagnosis codes and other criteria are used to determine whether IVIG is covered by Medicare Part B. If you have a condition that is not covered by Part B, you may still be covered by Medicare Part D if your condition is listed as an FDA-approved IVIG indication.

Speak to a IVIG Specialist

(877) 778-0318

Medicare IVIG Coverage Under Part B

IVIG is covered under Medicare Part B if the following criteria are met:

  1. IVIG is administered at home.
  2. IVIG is administered through an infusion pump.
  3. The treating physician has determined that the administration of IVIG at home is medically appropriate.
  4. The patient is diagnosed with primary immunodeficiency disease with one of the diagnosis codes listed below.

Medicare-covered Diagnosis Codes for Part B:

CodeDescription
D80.0Hereditary Hypogammaglobulinemia
D80.2Selective deficiency of immunoglobulin A (IgA)
D80.3Selective deficiency of immunoglobulin G (IgG) subclasses
D80.4Selective deficiency of immunoglobulin M (IgM) subclasses
D80.5Immunodeficiency with increased immunoglobulin M (IgM)
D80.6Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinemia.
D80.7ICD-10 diagnosis code for transient hypogammaglobulinemia of infancy.
D81.0Severe combined immunodeficiency (SCID) with reticular dysgenesis
D81.1Severe combined immunodeficiency (SCID) with low T-and B-cell numbers
D81.2Severe combined immunodeficiency (SCID) with low or normal B-cell numbers
D81.5Purine nucleoside phosphorylase (PNP) deficiency
D81.6Major histocompatibility complex class I deficiency
D81.7Major histocompatibility complex class II deficiency
D81.9Combined immunodeficiency, unspecified.
D81.89Other combined immunodeficiencies
D82.0Wiskott-Aldrich syndrome
D82.1DiGeorge syndrome.
D82.4 ICD-10 diagnosis code for hyperimmunoglobulin E (IgE) syndrome.
D83.0Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function
D83.1A billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes
D83.2Common variable immunodeficiency with autoantibodies to B- or T-cells
D83.8Other common variable immunodeficiencies
D83.9Common variable immunodeficiency, unspecified
G11.3Cerebellar ataxia with defective DNA repair
 

Can IVIG help?

Free IVIG Treatment Info | Difficulty In Diagnosing?
Schedule a Consultation

Medicare will pay 80% of the drug cost. The other 20% must be covered by a supplemental plan or by the patient. Under Part B, only the drug cost is covered. Supplies and infusion pumps are not covered unless they are for CIDP.

For CIDP, Medicare will also pay for 80% of the cost of supplies and infusion pumps. As of July 2021, only subcutaneous IG therapy (such as Hizentra and Hyqvia) for CIDP is covered under Part B.

Medicare IVIG Coverage Under Part D

For diagnoses that are not covered under Part B, Part D coverage may apply if the condition is an FDA-approved IVIG indication (see below). Medicare may also cover off-label use of IVIG when it is considered medically necessary and supported by sufficient evidence. For example, based on a reconsideration request received in December 2024, off-label use of IVIG for Susac syndrome has been rigorously evaluated, and off-label coverage has been expanded. Revision effective date: for services performed on or after 9/7/2025.

Medicare-Covered FDA-approved Indications for IVIG

  • Primary immunodeficiency
  • Myasthenia gravis
  • Chronic inflammatory demyelinating polyneuropathy (CIDP)
  • Immune thrombocytopenic purpura (ITP)
  • B-cell chronic lymphocytic leukemia (CLL)
  • Stiff-person syndrome
  • Bone marrow transplant/hematopoietic stem cell transplant
  • Dermatomyositis
  • Polymyositis
  • Multifocal motor neuropathy
  • HIV infection
  • Guillain-Barre syndrome
  • Lambert-Eaton myasthenic syndrome
  • Parvovirus B19-induced pure red cell aplasia
  • Kawasaki syndrome (pediatric)
  • Fetal/neonatal alloimmune thrombocytopenia
  • Isoimmune hemolytic disease of newborn
  • Neonatal hemochromatosis
  • Immune checkpoint inhibitor-related toxicity
  • CAR-T therapy-related hypogammaglobulinemia
  • Acquired red cell aplasia
  • Acute disseminated encephalomyelitis
  • Rasmussen encephalitis
  • Enteroviral meningoencephalitis
  • Autoimmune mucocutaneous blistering disease
  • Autoimmune hemolytic anemia
  • Autoimmune neutropenia
  • Systemic lupus erythematosus
  • Birdshot retinochoroidopathy
  • BK virus-associated nephropathy
  • Churg-Strauss syndrome
  • Hematophagocytic lymphohistiocytosis (HLH)
  • Macrophage Activation Syndrome (MAS)
  • Hyperimmunoglobulinemia E syndrome
  • Multiple myeloma
  • Opsoclonus-myoclonus
  • Post-transfusion purpura
  • Solid organ transplantation
  • Major surgery associated secondary immunosuppression
  • Hematologic malignancy-associated secondary immunosuppression
  • Major burns associated secondary immunosuppression
  • Collagen-vascular disease-associated secondary immunosuppression
  • Toxic epidermal necrolysis
  • Stevens-Johnson syndrome
  • Toxic shock syndrome
  • Toxic necrotizing fasciitis

Standard Part D benefit and copay structures apply. 

For more information on out-of-pocket expenses for Part D, visit the Q1Medicare site.

Nursing Costs for IVIG

IVIG nurse

Nursing costs for IVIG are covered under the Original Medicare or Medicare Advantage plan. For Original Medicare, 80% of the costs will be covered by the plan, and either a supplemental plan or the patient will be responsible for the remaining 20%. 

Costs will vary under Medicare Advantage. A full benefits investigation is necessary to determine the exact cost. Speak to an AmeriPharma® billing specialist for more information.

Consult an AmeriPharma® Billing Specialist

(877) 778-0318

Copay Assistance

AmeriPharma® offers assistance to help with any remaining copay you may have on IVIG after using Medicare. Using advanced software, AmeriPharma® will review all available funding sources and match you with a program that fits your needs. A copay specialist will help you with the application process.

For more information, speak to one of our specialists about how AmeriPharma® can help.

How to Enroll in Medicare

You may sign up for Medicare online, by phone, or in person at your local Social Security office.

Medicare enrollment is available during a 7-month enrollment period that starts 3 months before you turn 65. You must enroll in Medicare prior to turning 65 if you want your coverage to start on the month you turn 65. You may also enroll in Medicare up to 3 months after the month you turn 65, as outlined on the Medicare website. 

Individuals with specific disabilities may qualify for Medicare before they turn 65 years old.

The 2025 Medicare Open Enrollment period is from October 15 to December 7, 2025. Changes made during this time will go into effect on January 1, 2026.

During this time, Medicare enrollees are able to review and make changes to their current coverage, including cost, coverage, and provider and pharmacy networks.

Medicare’s Open Enrollment period is also known as the “annual enrollment period” or “AEP”. There may also be other times during the year when people can enroll in a plan, which are called “open enrollment” or “special enrollment” periods. 

For more information, visit medicare.gov.

The Inflation Reduction Act

Thanks to the Biden-Harris Administration’s Inflation Reduction Act (IRA), also known as the prescription drug law, people with Medicare prescription drug coverage (Part D) in 2025 will have the most comprehensive benefits since the program was launched in 2006. As of 2025, all people enrolled in Part D have their annual out-of-pocket prescription drug costs capped at $2,000 per year. For 2026, the OOP threshold is set to increase to $2100, reflecting growth/inflation adjustments. In 2026 the Medicare part D deductible is increasing from $590 in 2025 to $615 in 2026.

Additionally, the Medicare Prescription Payment Plan, which is offered by all Part D plans, allows people with Medicare Part D coverage the option to spread the costs of their prescription drugs over the calendar year.

Get IVIG Copay Assistance

IVIG Financial Assistance
Consult an IVIG Specialist

FAQs

Does Medicare cover IVIG for CIDP?

Yes. For CIDP, Medicare will pay for 80% of the cost of the drug and supplies. The other 20% must be covered by a supplemental plan or by the patient. As of July 2021, only subcutaneous IG therapy (such as Hizentra and Hyqvia) for CIDP is covered under Part B. 

Does Medicare cover IVIG for Guillain-Barre syndrome?

Yes. Medicare provides coverage for Guillain-Barre syndrome under Part D.

Does Medicare cover IVIG for Myasthenia Gravis?

Yes. Medicare provides coverage for Myasthenia Gravis under Part D.

Is Privigen covered by Medicare?

Yes, Privigen (J1459) is covered under Medicare Part B. 

Is Gamunex covered by Medicare?

Yes, Gamunex (J1561) is covered under Medicare Part B.

Sofosbuvir: Uses, Side Effects, Cost, and More

Sofosbuvir is an oral antiviral that is FDA-approved to treat certain forms of chronic hepatitis C in adults and children 3 years and older. In this article, we will discuss its uses, mechanism of action, success rate, side effects, cost, and more.

Speak to a Specialist

About Copay Assistance
(877) 778-0318

Sofosbuvir Quick Facts

  • Sofosbuvir belongs to a medication class called nucleotide polymerase inhibitors. 
  • The brand name of this medication is Sovaldi. No other brands of this medication are currently available. 
  • Gilead Sciences, Inc. received FDA approval in 2013 for Sovaldi. 
  • This medication should always be used with other antiviral medications to treat chronic hepatitis C. 

What Is Sofosbuvir?

Sofosbuvir is an antiviral agent. It is used with other antiviral medications to treat certain forms of chronic (long-lasting) hepatitis C. 

Hepatitis C is a viral infection of your liver. It causes liver inflammation and can lead to potentially life-threatening liver damage. The virus that causes this liver disease is known as the hepatitis C virus (HCV). 

According to the Centers for Disease Control (CDC), hepatitis C infection affects about 2.7 million people in the U.S. [1]

What Is Sofosbuvir Used For?

The FDA approved Sofosbuvir with other medicines (ribavirin and peginterferon alfa) to treat certain forms of chronic hepatitis C in adults. 

A healthcare provider may use this medication with ribavirin to treat certain types of chronic hepatitis in adults and children at least 3 years old. 

What Is the Mechanism of Action of Sofosbuvir?

Sofosbuvir blocks the activity of an enzyme that the hepatitis C virus needs to multiply. That way, it reduces the viral load (the amount of hepatitis C virus) in the body. 

What Is the Success Rate of Sofosbuvir?

According to recent data, using sofosbuvir with ribavirin can cure HCV in 90% of patients. Researchers think a similar success rate is achievable with a combination of sofosbuvir and other antivirals like daclatasvir, ledipasvir, or simeprevir [2].

How To Use Sofosbuvir Properly

This medication is available as an oral tablet and pellet in the following strengths:

  • Oral Tablets: 400 mg and 200 mg 
  • Oral Pellets: 200 mg and 150 mg 

Take the dosage exactly as prescribed and at the same time each day. Don’t take less, more, or take the medication for longer than prescribed. 

Never stop taking this medication without talking to your healthcare provider first. Follow the instructions on the prescription label. If you’re not sure how to take the medication, seek help from your prescriber or pharmacist.

You can swallow the tablets or oral pellets, with or without food. Avoid chewing your dose. 

You may also prepare a dose of the pellets with food. Sprinkle the pellets on one spoonful of pudding, chocolate syrup, mashed potato, or ice cream. Make sure the food, which should be non-acidic and soft, is at or below room temperature. 

Swallow all the mixture within 30 minutes. Avoid storing leftover mixture for future use. Instead, dispose of any unused mixture. 

Things To Know Before Taking This Medication

Inform your healthcare provider if you have:

  • Ever had a hepatitis B virus infection
  • Liver problems other than hepatitis C infection
  • Had a liver transplant
  • Serious kidney issues
  • Been on dialysis
  • HIV infection

Get Financial Assistance

Schedule a Consultation

Use in Pregnancy and Lactation

Before starting treatment, inform your prescriber if you are pregnant or plan to become pregnant. It is yet to be determined if this medication will harm the unborn baby.

Before starting treatment, inform your prescriber if you are breastfeeding or plan to breastfeed. It has yet to be determined if this medication passes into breast milk.

Sofosbuvir Dosages

Adult dose for chronic hepatitis C infection

400 mg per day with other antiviral(s) for 12 weeks to 24 weeks, depending on the type of hepatitis C infection. 

Dose for chronic hepatitis C infection in children

For children at least 3 years old, your healthcare provider will determine the dose of sofosbuvir tablets or oral pellets based on your child’s body weight.

Who Shouldn’t Get This Medication?

Because sofosbuvir is always used with other antiviral drugs, contraindications to those drugs also apply to the combination treatment. 

Sofosbuvir Side Effects

Common side effects

Woman on bed suffering from fatigue from taking sofosbuvir

When used with both pegylated interferon and ribavirin, common side effects can include:

  • Fatigue
  • Headache
  • Nausea
  • Trouble sleeping
  • Anemia (low blood cell count)

When used with ribavirin, common side effects can include:

  • Fatigue 
  • Headache

Talk to your provider if these effects don’t go away or worsen. 

Serious side effects

Hepatitis B virus reactivation

Taking this medication can reactivate the hepatitis B virus if you have ever had hepatitis B infection. Reactivated hepatitis B virus can lead to liver failure and death. Reactivation may happen during or after treatment with sofosbuvir. 

Thus, you will need to go through blood tests to check for hepatitis B virus before initiating therapy. Also, your healthcare provider will monitor you for reactivation during and after treatment with sofosbuvir.

Consult your healthcare provider immediately if you have:

  • Excessive tiredness
  • Yellowing of the skin or eyes
  • Loss of appetite
  • Nausea and vomiting
  • Pale stools
  • Upper right stomach pain
  • Dark urine

Bradycardia (slow heart rate)

In patients using a heart medicine called amiodarone, sofosbuvir may cause a decrease in heart rate. Before starting sofosbuvir, inform your healthcare provider if you are taking amiodarone.

If you’re taking amiodarone and sofosbuvir, contact your healthcare provider immediately if you have: 

  • Dizziness or fainting
  • Fatigue
  • Shortness of breath
  • Chest pain
  • Confusion
  • Memory problems
  • Malaise

Speak to a Specialist

(877) 778-0318

What To Do If You Miss a Dose

Take the missed dose immediately after you remember it. Take the next dose at the regular schedule and stick to the recommended schedule. Don’t double dose.

What To Do If You Overdose

Seek emergency medical care or call the poison control helpline at 1-800-222-1222.

How Should You Store This Medication?

  • Store oral tablets and pellets below 86°F in the original container. 
  • Keep all your medications out of reach of children.
  • Keep all your prescription and OTC medications away from excess heat, light, and moisture.

How Much Does Sofosbuvir Cost?

The amount you pay for your treatment can vary, depending on your insurance plan, geographical location, and pharmacy. Call your insurance provider to learn if your plan covers this medicine or if you need prior authorization.

According to an economic analysis, a 12-week course of treatment with sofosbuvir costs $84,000 [3]. Because sofosbuvir is never used alone, the cost of combination treatment will be higher. 
You can contact us if you are interested in exploring financial assistance options for sofosbuvir.

Hemophilia and Joint Health: How To Prevent and Treat Joint Damage

Joint damage is one of the most common and serious complications of hemophilia that can affect patients’ daily life activities. Typically patients with severe hemophilia are more at risk of joint damage than others with mild or moderate cases. 

Speak to a Specialist

About Copay Assistance
(877) 778-0318

Hemophilia is an inherited disorder in which the blood does not clot properly due to a deficiency in clotting proteins (factor VIII or IX). Patients with this blood disorder can bleed excessively, especially internally, even with minor injuries. 

Repeated internal bleeding in or around the joints can permanently damage the joints or lead to a condition called arthropathy (a type of joint disease) if not managed and treated properly.  

In this article, we will discuss hemophilia and joint health in detail. Specifically, we will explain how hemophilia affects joints and what precautions and treatments can be taken to prevent and treat joint damage. 

Hemophilia and Joint Health

Joint health is usually compromised in patients regardless of their type of hemophilia (A or B). Both types of hemophilia increase the risk of internal bleeding, particularly in the joints, in a condition known as hemarthrosis

When a patient experiences frequent bleeds (2 – 3 times in 6 months) in the same joints, it leads to chronic inflammation, pain, and eventually long-term joint damage. Usually, the joint damage begins after one severe bleeding episode. 

How Does Joint Damage Occur in Hemophilia Patients?

Patients with hemophilia usually experience joint damage similar to patients with arthritis. Damage occurs in two areas of the joints: the synovium and the cartilage. 

Damage to the Synovium

Synovium is a thin layer of soft-connective tissues that lines the inside of your joints and produces synovial fluids to reduce friction between bones and help joints move smoothly. This area (synovium) also has many blood vessels, which is why joint bleeding is common in hemophilia. 

When bleeding occurs in the joint, synovium absorbs blood to remove it from its cavity. As a result, the synovium gets thicker due to the accumulation of iron in the blood and becomes inflamed (or swollen). This condition is known as synovitis

Damage to the Cartilage

The inflamed synovium releases enzymes and inflammatory markers that break down the joint’s cartilage. Cartilage is the tough but flexible connective tissue that covers the ends of the bones and helps them move smoothly against each other. When the cartilage is damaged or destroyed,  the bones rub against each other, causing pain and further damage. 

Continuous bleeding and damage to the joints may cause joint deformity. As a result of persistent joint injury over time, the damaged joint develops arthritis (or inflammation of the joint) and chronic pain.

The joints that are mostly affected and get damaged due to repeated bleeds are the hinge joints, which include knees, ankles, and elbows. 

How Can You Prevent Joint Damage?

You can prevent joint damage by controlling or preventing the bleeding in the joint. Once the joint is damaged, it can be repaired, but it cannot be totally healthy again like it used to be before the damage. 

Below are the preventive measures you can take to reduce the risk of joint damage: 

Regular Treatment With Clotting Factor Replacement Therapy

If a bleed occurs, you should immediately seek treatment with clotting factor replacement therapy. During this therapy, a missing clotting factor is infused into your bloodstream. This will stop the bleeding and reduce the risk of long-term joint damage. 

Regular treatment with prophylactic therapy helps to reduce the frequency of bleeding episodes in the joints. 

Get Financial Assistance

Schedule a Consultation

RICE Treatment Strategies

RICE treatment strategies stand for Rest, Ice, Compression, and Elevation.

Man using ice pack on elbow joint
  1. Rest the affected joint to allow the bleeding to stop. Use a walker or crutches to walk and avoid weight-bearing exercise. 
  2. Ice the affected joint for 10 to 20 minutes every 4 to 6 hours daily. 
  3. Compression helps to limit bleeding and relieve pain. Wrap the elastic bandage around the injured point to compress the affected area. 
  4. Elevation decreases the pressure on the blood vessels and allows the blood to drain away from the joint. While resting, you can elevate the injured area to a position higher than your heart for 2 to 3 days. 

Regular Exercise

Regular physical activity, such as walking, swimming, or cycling, is recommended to maintain joint health and muscle strength. These exercises are generally safe and do not put pressure on joints. 

Balanced and Nutritious Diet

A balanced and nutritious diet can help maintain weight and overall joint health. A diet rich in anti-inflammatory foods, calcium and vitamin D, collagen-boosting foods, and adequate protein intake benefits joints by protecting and strengthening the joints’ tissues. 

Furthermore, proper education about early signs of joint bleeding to patients and caregivers can help them seek early treatment and prevent minor bleeds from causing severe and long-term damage. 

How Can You Treat Joint Damage?

Despite taking preventive measures, joint damage can still occur in some patients with severe hemophilia. In this case, doctors generally recommend some effective treatment procedures for treating joints, reducing pain, and improving joint functions. 

The following are some treatment procedures that you may undergo to treat joint damage: 

1. Synovectomy

Synovectomy involves the removal of synovium. This procedure aims to reduce the frequency of bleeding episodes, reduce chronic pain, and slow down or stop joint degeneration. Synovectomy is generally recommended to prevent the progression of joint disease (arthropathy). 

It is typically done in one of three ways: radioactive, arthroscopic, and surgical synovectomy. Your healthcare provider will choose the best option based on your condition. 

2. Joint Replacement Treatment

Joint replacement, also known as arthroplasty, is performed when the pain produced by joint damage interferes with daily activities and severely affects the patient’s quality of life. Knee and hip replacement are more common than shoulder, and ankle replacement. 

3. Fusion

Fusion, or arthrodesis, is a procedure in which painful joints are surgically removed and the bones are fused. You can consult your healthcare provider for the best treatment plan for your condition. 

Hemophilia and Joint Health: Summary

Joint damage is a common complication of hemophilia and requires immediate medical attention to prevent joint deformation and long-term disability. Hemophilia patients can avoid the risk of joint damage by following a healthy lifestyle. This includes things such as regular physical activity, receiving timely clotting replacement therapy, and maintaining balanced nutrition. For patients with joint damage, physical therapy, synovectomy, joint replacement therapy, and fusion can help to reduce pain and improve quality of life.

Severe Combined Immunodeficiency (SCID): A Rare, Life-Threatening Disorder in Infants

Severe combined immunodeficiency (SCID) is a rare but severe type of primary immunodeficiency disorder that appears in infancy (age 6 months or earlier). Children born with SCID have an incredibly weak immune system. Though they appear healthy at birth, common infections such as chicken pox, pneumonia, and meningitis can be life-threatening due to a severely compromised immune system.

Speak to a Specialist

About Copay Assistance
(877) 778-0318

In the United States, around 1 in 100,000 infants are born every year with SCID. In the past, many children with SCID died in early childhood due to repeated frequent infections and limited available treatments.  

However, thanks to recent advances in science, newborn screening, and early intervention can help successfully treat children with SCID. 

Let’s discuss the basics of SCID, including its cause, types, symptoms, risk factors, diagnosis, and available treatment. 

What Is Severe Combined Immunodeficiency?

Severe combined immunodeficiency, also known as “bubble boy or boy in the bubble syndrome,” is a group of hereditary (genetic) disorders that affects the immune system of newborns. This condition first came to light after the release of the 1976 television movie about David Vetter (a story focused on a boy who was born with SCID and spent his 12 years living in a plastic bubble to prevent infection). 

Children with SCID are highly susceptible to common infections due to a non-functional immune system. As a result, the body of a SCID child is unable to fight off certain bacteria, viruses, and fungi. This can eventually lead to an early death. 

What Happens in Severe Combined Immunodeficiency?

Normally, the immune system of a developing baby starts in the bone marrow, where stem cells differentiate into three different types of cells: platelets, blood cells, and white blood cells (WBCs). 

3D illustration of T-cells

WBCs, in particular, are the cells that help your body fight certain pathogens (e.g., bacteria, fungi, viruses) to prevent infection or disease. There are various types of WBCs, including lymphocytes, which are B cells and T cells that carry out the following functions: 

  • T cells identify, attack, and kill the pathogen.
  • B cells function as memory cells (cells that remember or memorize the infection-causing pathogen) and plasma cells (cells that produce antibodies in case the body is exposed to the pathogen again).

In children with SCID, both lymphocytes (T and B cells) are affected or nearly absent. As a result, the immune system becomes extremely weak and does not work properly as it should to fight off infection-causing pathogens. 

What Causes Severe Combined Immunodeficiency (SCID)?

SCID occurs due to genetic mutations in multiple genes on X chromosomes. These genes are primarily involved in the development and functioning of immune cells, such as B-cells, T-cells, and natural killer cells (NK cells). 

SCID is a recessive X-linked disorder and only affects men since they only have one X chromosome. Women can be carriers that pass the defective genes to male children. However, in more than 80% of cases, children with SCID do not show a family history of SCID. 

How Is Severe Combined Immunodeficiency (SCID) Classified?

Healthcare providers have classified SCID into various types based on the type of gene defects. In 15% of cases, gene defects are known. Below are some types of SCID:

Classical X-linked SCID

Classical X-linked SCID occurs as a result of a mutation in a gene (IL2RG gene) located on X chromosome. In this type, white blood cells grow and develop abnormally. As a result, patients with this condition have a low count of T cells, B cells, and natural killer cells that do not function. This type mainly affects males since they only have one copy of the X chromosome. 

    ADA Deficiency SCID 

    In this type, a mutation in the ADA gene causes a deficiency of the ADA enzyme that is needed for T cell survival. Doctors call this type ADA deficiency SCID

      Leaky SCID 

      In this type, a child has notable or even excess T cells that cause inflammation and damage to the body.

      Get IVIG Prior Authorization

      Schedule a Consultation

      How You Can Identify if Your Child Has Severe Combined Immunodeficiency (SCID)

      The signs and symptoms of SCID tend to appear between 3 to 6 months of age and generally include a frequent respiratory infection, common yeast infections, chronic diarrhea, and fungal pneumonia. Other notable symptoms can include:

      • Rashes
      • Ear infections
      • Slow growth
      • Trouble gaining weight
      • Infections that do not respond well to antibiotics
      • Recurrent thrush (fungal infection) in the mouth

      If your child shows the symptoms mentioned above, especially fungal pneumonia, consult your healthcare provider immediately for genetic testing and SCID screening. 

      What Is the Diagnosis Procedure for Severe Combined Immunodeficiency (SCID)?

      Early diagnosis and screening for SCID can increase the positive success rate of combating SCID disorder. A healthcare professional performs a heel prick blood test to check the level of T cells and antibodies in the child’s body. 

      Depending on the results of blood tests, further tests may be performed to check the genetic markers of SCID via genetic testing. 

      How Is SCID Treated?

      SCID is a severe condition and requires immediate pediatric emergency treatment. Without treatment, SCID children do not survive beyond the first year of life. However, early treatment can improve the prognosis significantly. Below are some of the treatment options currently available for SCID:

        Bone Marrow Transplant

        Bone marrow transplant is a standard and effective treatment for infants with SCID. In this procedure, blood-forming (also known as hematopoietic) stem cells from the bone marrow of matched donors are transplanted to SCID patients. This reconstitutes the immune system of SCID patients and allows them to develop functional immune systems.

        The donor for bone marrow transplants could be a close relative like healthy siblings or parents. However, in most cases, patients do not have matched sibling donors, so transplants from unrelated matched donors are often performed, which has a lower success rate than a matched-related donor. 

        Moreover, early bone marrow transplantation typically gives the best outcomes for SCID infants. For instance, researchers examined data from 240 infants with SCID and discovered that irrespective of the kind of stem cell donor, the infants who had transplants prior to the age of 3.5 months had the highest chance of survival.

          Enzyme Replacement Therapy

          Enzyme replacement therapy (ERT) like PEG-ADA is a treatment option for infants with ADA deficiency SCID. In this therapy, a drug is injected regularly to treat the ADA deficiency. This therapy helps prevent frequent infections, restore immune function, and indirectly support child growth by promoting better overall health. 

          However, ERT is only a temporary treatment option, and it is used until the patient finds a stem cell transplant donor. 

            Gene Therapy

            Gene therapy can be an effective treatment for some X-linked SCID. It is also an option for SCID infants who either are not eligible for stem cell transplants or are unable to find the right donor. 

            In this procedure, the healthcare provider obtains the stem cells of the SCID child and replaces the defective gene with a normal one in the laboratory. After that, stem cells with the new healthy gene are inserted back into the SCID child’s bone marrow. 

            Gene therapy is experimental and still in the clinical trials phase in the U.S. 

              Intravenous Immunoglobulin (IVIG)

              IVIG therapy is another effective treatment option for SCID infants to control the chances of recurrent infections. IVIG provides a wide array of antibodies to SCID patients that boost the immune system and help their bodies fight off infections. 

              Consult an IVIG Specialist

              (877) 778-0318

              Takeaway

              SCID is a rare but severe genetic disorder that can lead to death, even with common infections, if not diagnosed and treated in the first year of life. Gene therapy, IVIG, enzyme replacement therapy, and bone marrow transplants are available treatments to help your child live a healthy life. Consult your healthcare provider if you want genetic testing or have concerns about your child’s health.

              IVIG for Toxic Necrotizing Fasciitis: What the Evidence Says

              IVIG for toxic necrotizing fasciitis may be an option in certain cases. While a few studies show benefits, its use is controversial. 

              Consult an IVIG Specialist

              (877) 778-0318

              Highlights

              • Necrotizing fasciitis is a rare, aggressive bacterial infection. Delayed treatment may result in multiple organ failure and death.
              • Surgery and antibiotics are the mainstay of therapy; IVIG is an experimental treatment. 
              • IVIG may be an option if you’re critically ill and have unstable blood pressure.
              • It’s best to administer IVIG on a case-by-case basis. 
              • IVIG may be particularly effective in necrotizing fasciitis caused by Group A Streptococcus (GAS). 
              • More evidence from larger trials is needed to establish the benefits of IVIG for toxic necrotizing fasciitis. 

              A Quick Overview of Necrotizing Fasciitis

              Necrotizing fasciitis causes death (necrosis) of the fascia and tissues beneath your skin. The fascia is a thin layer of connective tissue that surrounds your muscles, bones, and organs.

              Other names of this condition are:

              • Flesh-eating disease
              • Streptococcal gangrene
              • Suppurative fasciitis

              Necrotizing fasciitis affects about four in one million Americans each year [1]. It can occur when a bacterium or several bacteria enter the body and produce toxins. These toxins limit blood supply to tissues and damage cells, causing pus-filled lesions. 

              If the toxins reach your bloodstream, it may result in toxic shock. 

              Bacteria associated with a necrotizing infection include:

              • Group A Streptococci (Streptococcus pyogenes)
              • Staphylococcus aureus
              • Klebsiella pneumoniae
              • Escherichia coli

              Can You Use IVIG for Toxic Necrotizing Fasciitis?

              Toxic necrotizing fasciitis Patient receiving IVIG treatment at home

              Possibly. Few studies have looked into the potential benefits of IVIG for necrotizing fasciitis. Below are some of them. 

              According to a 2015 case report, IVIG may be an option in critically ill patients with unstable blood pressure [2]. In this case, a person who didn’t respond to antibiotic therapy improved rapidly after receiving IVIG. 

              This result corroborates an earlier finding in which researchers noted that IVIG as an adjunct to antibiotics or surgery dramatically improved the outcome [3]. 

              According to the authors of this study, starting IVIG within 24 to 48 hours after the diagnosis could help prevent shock and multiple organ failure. 

              In a 2017 analysis, researchers analyzed over 4,000 cases of necrotizing fasciitis. Of them, 164 patients received IVIG therapy. They concluded that IVIG had no effect on death or length of hospital stay [4].

              The World Society of Emergency Surgery (WSES) guidelines recommend IVIG for necrotizing soft tissue infections caused by Streptococci and Staphylococci [5]. The recommendation is based on the potential of IVIG to neutralize bacterial toxins. 

              Get Your IVIG Dose

              At-Home Infusion
              Schedule a Consultation

              IVIG for Toxic Necrotizing Fasciitis: Understanding the Mechanism

              How IVIG benefits people with necrotizing fasciitis isn’t fully understood. Health experts believe IVIG may work by:

              • Neutralizing the bacterial toxins
              • Preventing abnormally rapid multiplication of certain immune cells
              • Reducing inflammation 

              IVIG for Toxic Necrotizing Fasciitis: The Challenges Ahead

              Despite promising results in case studies, several challenges still limit IVIG use for necrotizing fasciitis. 

              Researchers have yet to determine:

              • The most effective IVIG agent
              • The timing of therapy
              • The dose
              • The duration of treatment

              IVIG for Toxic Necrotizing Fasciitis: Frequently Asked Questions

              What is the role of IVIG in toxic shock syndrome?

              IVIG can be used as an adjunct to surgery and antibiotics to improve survival in people with toxic shock syndrome.

              What is the most effective treatment for necrotizing fasciitis?

              Antibiotic therapy and surgery to remove dead tissue are the most effective treatments for necrotizing fasciitis. 

              What is the drug of choice for necrotizing fasciitis?

              Ceftriaxone — a third-generation cephalosporin — is the drug of choice for early treatment. This medication is effective against gram-negative bacteria but has less potent gram-positive activity.